Ms.Riya Ann Philip
ISF College of Pharmacy, India
Title: The emergence of 3d printing in pharmaceuticals
Biography:
Ms.Riya Ann Philip,ISF College of Pharmacy, India
Abstract:
Abstract:
3D printing is a manufacturing method in which objects are made by fusing or depositing materials such as plastic, metal, ceramics, powders, liquids, or even living cells—in layers to produce a 3D object. This printing has ample number of applications and has acquired much regard in the medical era. Due to its constantly enhancing standard, the use of this technology on patients has increased immensely. It is also used to produce artificial tissues that can be used for testing drugs for the whole pharmaceutical industry. This process is also called additive manufacturing (AM), rapid prototyping (RP), or solid free-form technology (SFF). The printers are similar to inkjet printers but the end products are different. 3D printing medical devices are classified into three classes, viz., Class I, Class II and Class III including Low Risk Devices, Intermediate Risk Devices and High-Risk Devices respectively. The current applications of this technology in the field of medicine are prevalent in Medical Research, Education and Training and most importantly in Individual Patient Care. There are also several controversies and barriers regarding its safety and security, copyright concerns, patent, regulatory concerns etc. A study by Market Research Future (MRFR) reports that the Global 3D Printing Medical Devices Market is likely to witness exponential growth over the forecast period 2018 to 2023. The market is likely to expand at an approximate CAGR of 18% over the forecast period. In this review, we would like to throw light on the aforementioned technology and its effective application in medical field.